<?xml version="1.0" encoding="UTF-8"?>
<ref id="B12">
 <mixed-citation publication-type="journal">
  <name>
   <surname>Zeuzem</surname>
   <given-names>S</given-names>
  </name>
  <name>
   <surname>Feinman</surname>
   <given-names>SV</given-names>
  </name>
  <name>
   <surname>Rasenack</surname>
   <given-names>J</given-names>
  </name>
  <name>
   <surname>Heathcote</surname>
   <given-names>EJ</given-names>
  </name>
  <name>
   <surname>Lai</surname>
   <given-names>MY</given-names>
  </name>
  <name>
   <surname>Gane</surname>
   <given-names>E</given-names>
  </name>
  <name>
   <surname>O'Grady</surname>
   <given-names>J</given-names>
  </name>
  <name>
   <surname>Reichen</surname>
   <given-names>J</given-names>
  </name>
  <name>
   <surname>Diago</surname>
   <given-names>M</given-names>
  </name>
  <name>
   <surname>Lin</surname>
   <given-names>A</given-names>
  </name>
  <article-title>Peginterferon alfa-2a in patients with chronic hepatitis C</article-title>
  <source>N Engl J Med</source>
  <year>2000</year>
  <volume>343</volume>
  <fpage>1666</fpage>
  <lpage>1672</lpage>
  <pub-id pub-id-type="doi">10.1056/NEJM200012073432301</pub-id>
  <pub-id pub-id-type="pmid">11106715</pub-id>
 </mixed-citation>
</ref>
